𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The efficacy and safety of adalimumab in psoriatic arthritis

✍ Scribed by Christopher T. Ritchlin

Book ID
107553872
Publisher
Springer
Year
2006
Tongue
English
Weight
455 KB
Volume
8
Category
Article
ISSN
1523-3774

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adalimumab for long-term treatment of ps
Adalimumab for long-term treatment of psoriatic arthritis: Forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial
✍ Dafna D. Gladman; Philip J. Mease; Christopher T. Ritchlin; Ernest H. S. Choy; J πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 281 KB πŸ‘ 2 views

## Abstract ## Objective To evaluate the efficacy and safety of treatment with adalimumab, a fully human anti–tumor necrosis factor (anti‐TNF) monoclonal antibody, over 48 weeks in patients with moderate to severe psoriatic arthritis (PsA). ## Methods Patients who completed the Adalimumab Effect

Efficacy of infliximab in resistant psor
Efficacy of infliximab in resistant psoriatic arthritis
✍ Salvarani, Carlo ;Cantini, Fabrizio ;Olivieri, Ignazio ;Macchioni, Pierluigi ;Pa πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views